Company page

Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. (Ticker: CRVS) is a publicly traded company based in the United States, focusing on the development of innovative therapies for cancer treatment. With a market capitalization of approximately $1.1 billion, Corvus is dedicated to advancing its research and clinical programs to improve patient outcomes in oncology. The company is committed to addressing unmet medical needs through its unique approach to drug development.